Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Clinical trial NCT01316718 · COMPLETED
Trial details
- NCT number
- NCT01316718
- Sponsor
- University of Nottingham
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-09-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.